retatrutide triple agonist glp-1 gip glucagon Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more at our link in bio Reta GLP-3R (Retatrutide) 10mg |

H.JiangH.DingD.ColingD.et al

For the new study, the team looked at people with type 2 diabetes on GLP-1 receptor agonists or other types of diabetes drugs known as SGLT-2 inhibitors, or DPP-4 inhibitors

For those who value quality assurance but want to avoid injections, the pricing represents reasonable value

While the "low and slow" dosing method helps reduce side effects, tailored guidance ensures you can stick with the plan over the long haul

Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with progressive metastatic castration-resistant prostate cancer (mCRPC): Multi-centre phase I/II study [abstract]